Literature DB >> 17709844

Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?

Georges Saab, Ali Abu-Alfa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17709844     DOI： 10.1148/radiol.2443070351

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  3 in total

1.  Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.

Authors:  Constantina Chrysochou; Albert Power; Aladdin E Shurrab; Sayed Husain; Steven Moser; James Lay; Alan D Salama; Philip A Kalra
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 8.237

2.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

Review 3.  Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.

Authors:  Jeffrey G Penfield
Journal:  Pediatr Nephrol       Date:  2008-06-10       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.